Abstract:Freezing of gait (FOG) is a debilitating symptom of Parkinson's disease (PD) that impairs mobility and safety. Traditional detection methods face challenges due to intra and inter-patient variability, and most systems are tested in controlled settings, limiting their real-world applicability. Addressing these gaps, we present FOGSense, a novel FOG detection system designed for uncontrolled, free-living conditions. It uses Gramian Angular Field (GAF) transformations and federated deep learning to capture temporal and spatial gait patterns missed by traditional methods. We evaluated our FOGSense system using a public PD dataset, 'tdcsfog'. FOGSense improves accuracy by 10.4% over a single-axis accelerometer, reduces failure points compared to multi-sensor systems, and demonstrates robustness to missing values. The federated architecture allows personalized model adaptation and efficient smartphone synchronization during off-peak hours, making it effective for long-term monitoring as symptoms evolve. Overall, FOGSense achieves a 22.2% improvement in F1-score compared to state-of-the-art methods, along with enhanced sensitivity for FOG episode detection. Code is available: https://github.com/shovito66/FOGSense.
Abstract:The availability of continuous glucose monitors as over-the-counter commodities have created a unique opportunity to monitor a person's blood glucose levels, forecast blood glucose trajectories and provide automated interventions to prevent devastating chronic complications that arise from poor glucose control. However, forecasting blood glucose levels is challenging because blood glucose changes consistently in response to food intake, medication intake, physical activity, sleep, and stress. It is particularly difficult to accurately predict BGL from multimodal and irregularly sampled data and over long prediction horizons. Furthermore, these forecasting models must operate in real-time on edge devices to provide in-the-moment interventions. To address these challenges, we propose GlucoNet, an AI-powered sensor system for continuously monitoring behavioral and physiological health and robust forecasting of blood glucose patterns. GlucoNet devises a feature decomposition-based transformer model that incorporates patients' behavioral and physiological data and transforms sparse and irregular patient data (e.g., diet and medication intake data) into continuous features using a mathematical model, facilitating better integration with the BGL data. Given the non-linear and non-stationary nature of BG signals, we propose a decomposition method to extract both low and high-frequency components from the BGL signals, thus providing accurate forecasting. To reduce the computational complexity, we also propose to employ knowledge distillation to compress the transformer model. GlucoNet achieves a 60% improvement in RMSE and a 21% reduction in the number of parameters, using data obtained involving 12 participants with T1-Diabetes. These results underscore GlucoNet's potential as a compact and reliable tool for real-world diabetes prevention and management.
Abstract:Uncontrolled cell division in the brain is what gives rise to brain tumors. If the tumor size increases by more than half, there is little hope for the patient's recovery. This emphasizes the need of rapid and precise brain tumor diagnosis. When it comes to analyzing, diagnosing, and planning therapy for brain tumors, MRI imaging plays a crucial role. A brain tumor's development history is crucial information for doctors to have. When it comes to distinguishing between human soft tissues, MRI scans are superior. In order to get reliable classification results from MRI scans quickly, deep learning is one of the most practical methods. Early human illness diagnosis has been demonstrated to be more accurate when deep learning methods are used. In the case of diagnosing a brain tumor, when even a little misdiagnosis might have serious consequences, accuracy is especially important. Disclosure of brain tumors in medical images is still a difficult task. Brain MRIs are notoriously imprecise in revealing the presence or absence of tumors. Using MRI scans of the brain, a Convolutional Neural Network (CNN) was trained to identify the presence of a tumor in this research. Results from the CNN model showed an accuracy of 99.17%. The CNN model's characteristics were also retrieved. In order to evaluate the CNN model's capability for processing images, we applied the features via the following machine learning models: KNN, Logistic regression, SVM, Random Forest, Naive Bayes, and Perception. CNN and machine learning models were also evaluated using the standard metrics of Precision, Recall, Specificity, and F1 score. The significance of the doctor's diagnosis enhanced the accuracy of the CNN model's assistance in identifying the existence of tumor and treating the patient.
Abstract:Parkinson's disease (PD) is a progressive neurological disorder that impacts the quality of life significantly, making in-home monitoring of motor symptoms such as Freezing of Gait (FoG) critical. However, existing symptom monitoring technologies are power-hungry, rely on extensive amounts of labeled data, and operate in controlled settings. These shortcomings limit real-world deployment of the technology. This work presents LIFT-PD, a computationally-efficient self-supervised learning framework for real-time FoG detection. Our method combines self-supervised pre-training on unlabeled data with a novel differential hopping windowing technique to learn from limited labeled instances. An opportunistic model activation module further minimizes power consumption by selectively activating the deep learning module only during active periods. Extensive experimental results show that LIFT-PD achieves a 7.25% increase in precision and 4.4% improvement in accuracy compared to supervised models while using as low as 40% of the labeled training data used for supervised learning. Additionally, the model activation module reduces inference time by up to 67% compared to continuous inference. LIFT-PD paves the way for practical, energy-efficient, and unobtrusive in-home monitoring of PD patients with minimal labeling requirements.